Bliss GVS Pharma Ltd. Manufacturing Facility Achieves WHO-GMP Compliance
Bliss GVS Pharma Ltd. has announced that its manufacturing facility has received confirmation of compliance with Good Manufacturing Practices (GMP) standards set by the World Health Organization (WHO).The facility, located at Survey No. 43 & 44, Vevoor Village, Palghar (East), District Palghar, 401404, Maharashtra, India, received the Inspection Closure Report from the World Health Organization (WHO) in Geneva, Switzerland.
The achievement confirms that the Company's manufacturing processes meet the stringent GMP standards published by the WHO. The company noted that this milestone reflects its continued commitment to quality assurance, operational excellence, and safety across its manufacturing operations.
BLISSGVS Stock Price Movement
Today, Bliss GVS Pharma Limited shares gained 8.32% to close at ₹434.45, marking a strong day in the Pharmaceuticals sector. The stock finished the session having reached its 52-week high and saw substantial activity with a traded volume of 3.87 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.